Evidence map›Paper›PMID 14652754›Full record

ArticleVirchows Archiv : an international journal of pathology2004

Vitamin D3 modulation of plasminogen activator inhibitor type-1 in human breast carcinomas under organ culture.

Edson Mantovani Barbosa, Sueli Nonogaki, Maria Lucia Hirata Katayama, Maria Aparecida Azevedo Koike Folgueira, Venâncio Ferreira Avancini Alves, Maria Mitzi Brentani

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. The Perspective of Vitamin D on suPAR-Related AKI in COVID-19.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Edson Mantovani BarbosaInstituto Brasileiro do Controle do Cancer, Avenida Alcântara Machado 2576, CEP 03102-002, São Paulo, SP, Brasil.
Sueli Nonogaki
Maria Lucia Hirata Katayama
Maria Aparecida Azevedo Koike Folgueira
Venâncio Ferreira Avancini Alves
Maria Mitzi Brentani
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRInstituto Adolfo Lutz · BRInstituto Brasileiro de Controle do Câncer · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urokinase plasminogen activator (uPA), its cell-bound receptor (uPAR) and its main inhibitor plasminogen activator type 1 (PAI-1) are present primarily in stromal cells in invasive breast carcinoma. The purpose of this study was to investigate the regulation by 1,25 dihydroxyvitamin-D3 (VD3) of these invasion-associated markers expressed in breast cancer tumors under organ culture, which preserves the interacting network of tumor and stromal cells. Breast carcinoma slices (30 cases), obtained using the Krumdieck tissue slicer, cultured for 48 h in the presence or absence of 100 nM vitamin D3, were embedded in formalin-fixed paraffin. uPA, uPAR, PAI-1 and VD3 receptor (VDR) were analyzed by immunohistochemistry, and their expression, detected in tumor cells and fibroblasts of the specimens, was not statistically changed by culture conditions. The proportion of cases expressing uPA, uPAR and PAI-1 was not affected by VD3 in epithelial cells, but the fraction of cases displaying strong PAI-1 reactivity in fibroblasts was reduced ( P=0.016) compared with control slices. Fibroblasts isolated from invasive ductal carcinomas and from normal breast tissues expressed higher VDR mRNA levels than epithelial cells. In cultured tumor fibroblasts, PAI-1 immunostaining and mRNA levels were reduced by VD3-limiting fibroblast contribution to invasion.

Indexed as

Blotting, NorthernBreast NeoplasmsCarcinoma, DuctalCell Line, TumorCholecalciferolGene Expression Regulation, NeoplasticHumansImmunohistochemistryOrgan Culture TechniquesPlasminogen Activator Inhibitor 1Receptors, CalcitriolReceptors, Cell SurfaceReceptors, Urokinase Plasminogen ActivatorRNA, MessengerUrokinase-Type Plasminogen ActivatorCholecalciferolPlasminogen Activator Inhibitor 1PLAUR protein, humanReceptors, CalcitriolReceptors, Cell SurfaceReceptors, Urokinase Plasminogen ActivatorRNA, MessengerUrokinase-Type Plasminogen Activator

Identifiers

PMID14652754
OpenAlexW2073998172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.